Schizophrenia Research
Volume 93, Issue 1 , Pages 23-32 , July 2007

Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: A single-voxel 1H spectroscopy study

  • Jeffrey A. Stanley

      Affiliations

    • Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, 48201, United States
    • Western Psychiatric Institute and Clinic, Pittsburgh, PA, 15213, United States
    • Corresponding Author InformationCorresponding author. University Health Center 9B-28, 4201 St. Antoine Street, Detroit, MI, 48201, United States. Tel.: +1 313 577 9090; fax: +1 313 577 5900.
    • ,
  • Madhuri Vemulapalli

      Affiliations

    • Western Psychiatric Institute and Clinic, Pittsburgh, PA, 15213, United States
    • ,
  • Jeffrey Nutche

      Affiliations

    • Western Psychiatric Institute and Clinic, Pittsburgh, PA, 15213, United States
    • ,
  • Debra M. Montrose

      Affiliations

    • Western Psychiatric Institute and Clinic, Pittsburgh, PA, 15213, United States
    • ,
  • John A. Sweeney

      Affiliations

    • Psychiatry, University of Illinois at Chicago, Chicago, IL 60612, United States
    • ,
  • Jay W. Pettegrew

      Affiliations

    • Western Psychiatric Institute and Clinic, Pittsburgh, PA, 15213, United States
    • ,
  • Frank P. MacMaster

      Affiliations

    • Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, 48201, United States
    • ,
  • Matcheri S. Keshavan

      Affiliations

    • Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI, 48201, United States
    • Western Psychiatric Institute and Clinic, Pittsburgh, PA, 15213, United States

Received 24 November 2006 ,Revised 18 March 2007 ,Accepted 21 March 2007.

References 

  1. Abbott C, Bustillo J. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr. Opin. Psychiatry. 2006;19:135–139
  2. Alaghband-Rad J, McKenna K, Gordon CT, Albus KE, Hamburger SD, Rumsey JM, et al. Childhood-onset schizophrenia: the severity of premorbid course. J. Am. Acad. Child Adolesc. Psych. 1995;34:1273–1283
  3. Alda M, Ahrens B, Lit W, Dvorakova M, Labelle A, Zvolsky P, et al. Age of onset in familial and sporadic schizophrenia. Acta Psychiatr. Scand. 1996;93:447–450
  4. Ambrosini PJ, Metz C, Prabucki K, Lee JC. Videotape reliability of the third revised edition of the K-SADS. J. Am. Acad. Child Adolesc. Psych. 1989;28:723–728
  5. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. Washington, D.C.: American Psychiatric Association; 1994;
  6. Asarnow JR, Tompson MC, Goldstein MJ. Childhood-onset schizophrenia: a followup study. Schizophr. Bull. 1994;20:599–617
  7. Badura F, Trott GE, Mehler-Wex C, Scheuerpflug P, Hofmann E, Warmuth-Metz M, et al. A study of cranial computer tomograms in very early and early onset schizophrenia. J. Neural Transm. 2001;108:1335–1344
  8. Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, Noll DC, et al. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch. Gen. Psychiatry. 2001;58:280–288
  9. Bartha R, al-Semaan YM, Williamson PC, Drost DJ, Malla AK, Carr TJ, et al. A short echo proton magnetic resonance spectroscopy study of the left mesial-temporal lobe in first-onset schizophrenic patients. Biol. Psychiatry. 1999;45:1403–1411
  10. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 2003;28:941–953
  11. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CT, et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 1996;153:1554–1563
  12. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry. 1998;43:641–648
  13. Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, et al. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 1998;155:1376–1383
  14. Bertolino A, Sciota D, Brudaglio F, Altamura M, Blasi G, Bellomo A, et al. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Am. J. Psychiatry. 2003;160:483–489
  15. Bettes BA, Walker E. Positive and negative symptoms in psychotic and other psychiatrically disturbed children. J. Child Psychol. Psychiatry. 1987;28:555–568
  16. Bhakoo KK, Pearce D. In vitro expression of N-acetyl aspartate by oligodendrocytes: implications for proton magnetic resonance spectroscopy signal in vivo. J. Neurochem. 2000;74:254–262
  17. Brambilla P, Stanley JA, Sassi RB, Nicoletti M, Mallinger AG, Keshavan MS, et al. 1H MRS study of dorso-lateral prefrontal cortex in healthy individuals before and after lithium administration. Neuropsychopharmacology. 2004;29:1918–1924
  18. Brooks WM, Hodde-Vargas J, Vargas LA, Yeo RA, Ford CC, Hendren RL. Frontal lobe of children with schizophrenia spectrum disorders: a proton magnetic resonance spectroscopic study. Biol. Psychiatry. 1998;43:263–269
  19. Bustillo JR, Rowland LM, Lauriello J, Petropoulos H, Hammond R, Hart B, et al. High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia. Am. J. Psychiatry. 2002;159:130–133
  20. Cecil KM, Lenkinski RE, Gur RE, Gur RC. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia. Neuropsychopharmacology. 1999;20:131–140
  21. Chakraborty G, Mekala P, Yahya D, Wu G, Ledeen RW. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 2001;78:736–745
  22. Choe BY, Suh TS, Shinn KS, Lee CW, Lee C, Paik IH. Observation of metabolic changes in chronic schizophrenia after neuroleptic treatment by in vivo hydrogen magnetic resonance spectroscopy. Invest. Radiol. 1996;31:345–352
  23. Church SM, Cotter D, Bramon E, Murray RM. Does schizophrenia result from developmental or degenerative processes?. J. Neural Transm., Suppl. 2002;129–147
  24. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr. Bull. 2003;29:633–651
  25. DeLisi LE. The significance of age of onset for schizophrenia. Schizophr. Bull. 1992;18:209–215
  26. Fannon D, Simmons A, Tennakoon L, O'Ceallaigh S, Sumich A, Doku V, et al. Selective deficit of hippocampal N-acetylaspartate in antipsychotic-naive patients with schizophrenia. Biol. Psychiatry. 2003;54:587–598
  27. Feinberg I. Schizophrenia and late maturational brain changes in man. Psychopharmacol. Bull. 1982;18:29–31
  28. Frahm J, Merboldt KD, Haenicke W. Localized proton spectroscopy using stimulated echoes. J. Magn. Reson. 1987;72:502–508
  29. Giedd JN, Blumenthal J, Jeffries NO, Castellanos FX, Liu H, Zijdenbos A, et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat. Neurosci. 1999;2:861–863
  30. Gimenez M, Junque C, Perez M, Vendrell P, Baeza I, Salamero M, et al. Basal ganglia N-acetylaspartate correlates with the performance in the procedural task ‘Tower of Hanoi’ of neuroleptic-naive schizophrenic patients. Neurosci. Lett. 2003;347:97–100
  31. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc. Natl. Acad. Sci. U. S. A. 2004;101:8174–8179
  32. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J. Comp. Neurol. 1997;387:167–178
  33. Huttenlocher PR, deCourten C, Garey LJ, van der Loos H. Synaptogenesis in human visual cortex-evidence for synapse elimination during normal development. Neurosci. Lett. 1982;33:247–252
  34. Isohanni M, Isohanni I, Koponen H, Koskinen J, Laine P, Lauronen E, et al. Developmental precursors of psychosis. Curr. Psychiatry Rep. 2004;6:168–175
  35. Keshavan MS, Beckwith C, Bagwell W, Pettegrew JW, Krishnan KR. An objective method for edge detection in M.R.I., morphometry. Eur. Psychiatr. 1994;9:205–207
  36. Keshavan MS, Anderson S, Beckwith C, Nash K, Pettegrew J, Ranga K, et al. A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging. Psychiatry Res. 1995;61:53–60
  37. Keshavan MS, Stanley JA, Pettegrew JW. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings-part. Biol. Psychiatry. 2000;48:369–380
  38. Keshavan MS, Haas G, Miewald J, Montrose DM, Reddy R, Schooler NR, et al. Prolonged untreated illness duration from prodromal onset predicts outcome in first episode psychoses. Schizophr. Bull. 2003;29:757–769
  39. Lipska BK, Weinberger DR. A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox. Res. 2002;4:469–475
  40. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol. Psychiatry. 1999;45:1128–1137
  41. McClellan J, McCurry C, Snell J, DuBose A. Early-onset psychotic disorders: course and outcome over a 2-year period. J. Am. Acad. Child Adolesc. Psychiatry. 1999;38:1380–1388
  42. Mehler C, Warnke A. Structural brain abnormalities specific to childhood-onset schizophrenia identified by neuroimaging techniques. J. Neural Transm. 2002;109:219–234
  43. Molina V, Sanchez J, Reig S, Sanz J, Benito C, Santamarta C, et al. N-acetyl-aspartate levels in the dorsolateral prefrontal cortex in the early years of schizophrenia are inversely related to disease duration. Schizophr. Res. 2005;73:209–219
  44. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder?. Br. Med. J. 1987;295:681–682
  45. Nicolson R, Brookner FB, Lenane M, Gochman P, Ingraham LJ, Egan MF, et al. Parental schizophrenia spectrum disorders in childhood-onset and adult-onset schizophrenia. Am. J. Psychiatry. 2003;160:490–495
  46. Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, et al. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study. J. Psychiatr. Res. 2007;41:625–634
  47. O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, et al. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. NeuroImage. 2004;21:1781–1789
  48. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol. Rep. 1962;10:428–437
  49. Pettegrew JW, Keshavan MS, Panchalingam K, Strychor S, Kaplan DB, Tretta MG, et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 1991;48:563–568
  50. Pouwels PJ, Brockmann K, Kruse B, Wilken B, Wick M, Hanefeld F, et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr. Res. 1999;46:474–485
  51. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 1993.;30:672–679
  52. Rakic P, Bourgeois J-P, Eckenhoff MF, Zecevic N, Goldman-Rakic PS. Concurrent overproduction of synapses in diverse regions of the primate cerebral cortex. Science. 1986;232:232–235
  53. Remschmidt H. Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry. J. Neural Transm. 2002;109:101–117
  54. Ritsner M, Amir S, Koronyo-Hamaoui M, Gak E, Ziv H, Halperin T, et al. Association study of CAG repeats in the KCNN3 gene in Israeli patients with major psychosis. Psychiatr. Genet. 2003;13:143–150
  55. Ross CA, Pearlson GD. Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends Neurosci. 1996;19:171–176
  56. Seeger U, Klose U, Mader I, Grodd W, Nagele T. Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases. Magn. Reson. Med. 2003;49:19–28
  57. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol. Psychiatry. 1999;45:17–25
  58. Stanley JA. In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders. Can. J. Psychiatry. 2002;47:315–326
  59. Stanley JA, Drost DJ, Williamson PC, Thompson RT. The use of a priori knowledge to quantify short echo in vivo 1H MR spectra. Magn. Reson. Med. 1995;34:17–24
  60. Stanley JA, Williamson PC, Drost DJ, Rylett RJ, Carr TJ, Malla A, et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schizophr. Bull. 1996;22:597–609
  61. Steen RG, Hamer RM, Lieberman JA. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology. 2005;30:1949–1962
  62. Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am. J. Psychiatry. 2002;159:1944–1946
  63. Thomas MA, Ke Y, Levitt J, Caplan R, Curran J, Asarnow R, et al. Preliminary study of frontal lobe 1H MR spectroscopy in childhood-onset schizophrenia. J. Magn. Reson. Imaging. 1998;8:841–846
  64. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R, et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:11650–11655
  65. Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 1993;13:981–989
  66. van der Knaap MS, van der Grond J, Luyten PR, den Hollander JA, Nauta JJ, Valk J. 1H and 31P magnetic resonance spectroscopy of the brain in degenerative cerebral disorders. Ann. Neurol. 1992;31:202–211
  67. Weinberger DR. From neuropathology to neurodevelopment. Lancet. 1995;346:552–557

PII: S0920-9964(07)00154-5

doi: 10.1016/j.schres.2007.03.028

Schizophrenia Research
Volume 93, Issue 1 , Pages 23-32 , July 2007

Article Tools

* Image Usage & Resolution